Skip to main content

Abdominoplasty

1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
Botulinum Neurotoxin Serotype EPhase 21 trial
Active Trials
NCT03429556Terminated23Est. Jul 2018
Labcorp
LabcorpBURLINGTON, NC
1 program
Autologous glueN/A
Regen Lab
Regen LabSwitzerland - Le Mont-sur-Lausanne
1 program
Autologous glueN/A1 trial
Active Trials
NCT02930447Unknown56Est. Dec 2022
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
Lactated Ringer's Fluid Bolus Response to Low Urinary OutputN/A1 trial
Active Trials
NCT05939518Completed51Est. Aug 2023
Calico
CalicoLONG BEACH, CA
1 program
CPL-01PHASE_21 trial
Active Trials
NCT04182880CompletedEst. Feb 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CalicoCPL-01
AbbVieBotulinum Neurotoxin Serotype E
Regen LabAutologous glue
Jerusalem PharmaceuticalsLactated Ringer's Fluid Bolus Response to Low Urinary Output

Clinical Trials (4)

Total enrollment: 130 patients across 4 trials

NCT04182880CalicoCPL-01

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

Start: Jan 2020Est. completion: Feb 2020
Phase 2Completed
NCT03429556AbbVieBotulinum Neurotoxin Serotype E

Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty

Start: May 2018Est. completion: Jul 201823 patients
Phase 2Terminated
NCT02930447Regen LabAutologous glue

Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty

Start: Jan 2021Est. completion: Dec 202256 patients
N/AUnknown
NCT05939518Jerusalem PharmaceuticalsLactated Ringer's Fluid Bolus Response to Low Urinary Output

Fluid Therapy and Glycocalyx Shedding During Moderate Surgery

Start: May 2020Est. completion: Aug 202351 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.